AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
46.68
+0.47 (1.02%)
At close: Jan 21, 2026, 4:00 PM EST
46.68
0.00 (0.00%)
After-hours: Jan 21, 2026, 4:11 PM EST
AnaptysBio Stock Forecast
Stock Price Forecast
The 11 analysts that cover AnaptysBio stock have a consensus rating of "Buy" and an average price target of $60.18, which forecasts a 28.92% increase in the stock price over the next year. The lowest target is $20 and the highest is $100.
Price Target: $60.18 (+28.92%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 4 |
| Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 12 | 12 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $55 → $78 | Buy | Maintains | $55 → $78 | +67.10% | Jan 20, 2026 |
| UBS | UBS | Hold → Strong Buy Initiates $20 → $70 | Hold → Strong Buy | Initiates | $20 → $70 | +49.96% | Jan 7, 2026 |
| Barclays | Barclays | Buy Maintains $70 → $55 | Buy | Maintains | $70 → $55 | +17.82% | Dec 17, 2025 |
| Stifel | Stifel | Strong Buy Maintains $80 → $56 | Strong Buy | Maintains | $80 → $56 | +19.97% | Dec 11, 2025 |
| Wedbush | Wedbush | Buy Reiterates $50 | Buy | Reiterates | $50 | +7.11% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
214.97M
from 91.28M
Increased by 135.51%
Revenue Next Year
127.21M
from 214.97M
Decreased by -40.82%
EPS This Year
-1.25
from -5.12
EPS Next Year
-4.66
from -1.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 242.1M | 152.3M | ||||
| Avg | 215.0M | 127.2M | ||||
| Low | 158.8M | 87.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 165.3% | -29.2% | ||||
| Avg | 135.5% | -40.8% | ||||
| Low | 73.9% | -59.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.51 | -2.37 | ||||
| Avg | -1.25 | -4.66 | ||||
| Low | -3.08 | -7.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.